Form 4: Applied Therapeutics Executive Chairman Receives Stock and Option Grants

John Johnson, Executive Chairman of Applied Therapeutics, Inc., was granted 500,000 restricted stock units and 1,000,000 stock options as compensation.

Summary

• John Johnson, the Executive Chairman of Applied Therapeutics, Inc., received 500,000 restricted stock units (RSUs) and 1,000,000 stock options on December 19, 2024.
• The RSUs and stock options were granted outside of the company's 2019 Equity Incentive Plan, under the inducement grant exception of Nasdaq Rule 5635(c).
• The RSUs represent a contingent right to receive one share of the company's common stock each.
• Both the RSUs and stock options vest in equal annual installments over the first two anniversaries of the grant date, contingent on continued service.
• The stock options have an exercise price of $1.02 and expire on December 19, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally viewed positively as it aligns executive interests with company performance. There are no indications of negative sentiment.

Positives

• The grants of RSUs and stock options serve as an incentive for the Executive Chairman to continue providing services to the company.
• The vesting schedule aligns the Executive Chairman's interests with the long-term performance of the company.

Risks

• The vesting of the RSUs and stock options is contingent on the Executive Chairman's continued service, which could be a risk if he were to leave the company before the vesting period is complete.

Industry Context

The granting of stock options and restricted stock units is a common practice in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• The use of stock options and restricted stock units as part of executive compensation is standard practice in the biotech industry, similar to companies like BioMarin Pharmaceutical and Vertex Pharmaceuticals.
• The vesting schedule of two years is also a common practice to ensure long-term alignment of interests between executives and shareholders.

Stakeholder Impact

• The grants of stock options and restricted stock units may have a minor dilutive effect on existing shareholders.
• The grants are intended to incentivize the Executive Chairman, which could ultimately benefit shareholders through improved company performance.

Key Dates

Keywords

stock options, restricted stock units, executive compensation, insider trading, equity incentive, APLT, Applied Therapeutics